VOGLIBOSE

Voglibose is an alpha‑glucosidase inhibitor delaying carbohydrate absorption, used for postprandial hyperglycemia. Side effects include flatulence, diarrhea, abdominal discomfort, and rare liver enzyme changes.

SKU: 94ddedf17649 Category: Tag:

Product Description


Mechanism of Action

VOGLIBOSE (ID 27829) exhibits a high‑dimensional biochemical interaction matrix spanning signalling‑axis disruption, catalytic‑domain modulation, mitochondrial‑network recalibration, ion‑flux redistribution, cytoskeletal‑architecture remodelling, membrane‑potential rebalancing and transcription‑factor pathway restructuring. Its molecular topology supports interaction with catalytic residues, allosteric regulators, transmembrane helices, nucleotide‑binding pockets, redox‑buffer modules and polymeric scaffolding complexes, enabling wide‑band influence across metabolic, structural, genomic and electrophysiological domains.

Mechanistically, VOGLIBOSE may reshape phosphorylation maps across ERK/MAPK/JNK/p38 axes, alter PI3K–AKT survival‑bias, modulate G‑protein coupling geometry, redistribute Ca²⁺ microdomain waveforms, adjust IP₃/DAG signalling topology and recalibrate cAMP–PKA amplitude. Mitochondrial impacts include ETC‑complex rebalancing, ATP/ADP cycle modulation, ROS‑threshold displacement, mitochondrial membrane‑potential polarity shifts and cross‑organelle stress signalling.

High‑Precision Research Applications

  • Kinome‑scale interference & catalytic‑cascade modelling
  • High‑resolution docking & conformational‑flow prediction
  • UPR/ER‑stress & autophagy/mitophagy integration networks
  • Full multi‑omics reconstruction (RNA‑seq, proteomics, phosphoproteomics, metabolomics)
  • Cytoskeletal force‑mapping & polymer turnover dynamics
  • Cell‑fate modelling: apoptosis, necroptosis, ferroptosis, parthanatos
  • AI‑driven SAR/QSAR predictive simulation

Toxicodynamics & Cellular Hazard Spectrum

  • Excessive ROS accumulation & antioxidant‑buffer collapse
  • Mitochondrial fragmentation or ETC suppression
  • Hyper‑disruption of Na⁺/K⁺/Ca²⁺ ionic‑gradients
  • Cytoskeletal degradation & membrane‑integrity failure
  • Inflammatory master‑switch activation (NF‑κB/STAT/IRF)
  • Multi‑axis programmed‑cell‑death induction
  • Epigenetic drift across methylation & acetylation layers

For expert laboratory research only — not intended for biological use.

Datasheet


Molecular Formula

C10H21NO7

Molecular Weight

267.28 g/mol

CAS Number

83480-29-9

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

1.90e+02 g/L

Purity

Purity information is available upon request (COA).

Synonym

voglibose; 83480-29-9; Basen; Glustat; Voglibosa

IUPAC/Chemical Name

(1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol

InChl Key

FZNCGRZWXLXZSZ-CIQUZCHMSA-N

InChl Code

InChI=1S/C10H21NO7/c12-2-5(3-13)11-6-1-10(18,4-14)9(17)8(16)7(6)15/h5-9,11-18H,1-4H2/t6-,7-,8+,9-,10-/m0/s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/444020;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download